PATH241213C23000
- 0.00
- 0.000.00%
UiPath Newsroom
Is UiPath (PATH) Ready for AI Disruption? Analysts Weigh In
UiPath Initiated at Sell by UBS
UiPath Analyst Ratings
UBS Initiates UiPath(PATH.US) With Sell Rating, Announces Target Price $14
Uipath Insider Sold Shares Worth $858,699, According to a Recent SEC Filing
2025 Investment Themes: AI, Energy, Defense Redefine US Markets
Why UiPath (PATH) Might Be Well Poised for a Surge
UiPath Inc. (PATH) Reports Strong Q3 2025 Results With 9% Revenue Growth, Gains Momentum With AI-Powered Automation
UiPath's Mixed Outlook: Strong Execution Amid AI Disruption Concerns
UiPath | 10-Q: Q3 2025 Earnings Report
Top Names With Growth at a Reasonable Price According to GARP
Here Is What to Know Beyond Why UiPath, Inc. (PATH) Is a Trending Stock
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $15 to $18
UiPath Price Target Raised to $16.00/Share From $15.00 by Barclays
UiPath Price Target Raised to $16.00/Share From $15.00 by Morgan Stanley
UiPath Price Target Raised to $16.00/Share From $15.00 by BMO Capital
UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'
UiPath Price Target Maintained With a $16.00/Share by RBC Capital
UiPath Is Maintained at Overweight by JP Morgan
JP Morgan Maintains Overweight on UiPath, Raises Price Target to $18